| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non–Small-Cell Lung Cancer
|
Wong, Kit Man
|
|
2017
|
18 |
1 |
p. e41-e47
nvt p.
|
artikel
|
| 2 |
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America
|
Raez, Luis E.
|
|
2017
|
18 |
1 |
p. e71-e79
nvt p.
|
artikel
|
| 3 |
Clinical Response to Everolimus of EGFR–Mutation-Positive NSCLC With Primary Resistance to EGFR TKIs
|
Matsuoka, Hiromichi
|
|
2017
|
18 |
1 |
p. e85-e87
nvt p.
|
artikel
|
| 4 |
Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non–Small-Cell Lung Cancer
|
Kim, Young Hun
|
|
2017
|
18 |
1 |
p. e13-e20
nvt p.
|
artikel
|
| 5 |
Consequences of Late-Stage Non–Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes
|
Murton, Andrew J.
|
|
2017
|
18 |
1 |
p. e1-e11
nvt p.
|
artikel
|
| 6 |
Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis
|
Lokhandwala, Tasneem
|
|
2017
|
18 |
1 |
p. e27-e34
nvt p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2017
|
18 |
1 |
p. A6-
1 p.
|
artikel
|
| 8 |
Effect of Accurate Staging Using Positron Emission Tomography on the Outcomes of Prophylactic Cranial Irradiation in Patients With Limited Stage Small-Cell Lung Cancer
|
Choi, Mihong
|
|
2017
|
18 |
1 |
p. 77-84
8 p.
|
artikel
|
| 9 |
Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non–Small-Cell Lung Cancer
|
Wakelee, Heather
|
|
2017
|
18 |
1 |
p. 50-59
10 p.
|
artikel
|
| 10 |
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non–Small-Cell Lung Cancer
|
Hirsch, Fred R.
|
|
2017
|
18 |
1 |
p. 43-49
7 p.
|
artikel
|
| 11 |
Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non–Small-cell Lung Cancer
|
Gandara, David R.
|
|
2017
|
18 |
1 |
p. 1-4
4 p.
|
artikel
|
| 12 |
Immunotherapy Comes of Age in Lung Cancer
|
Khanna, Priyanka
|
|
2017
|
18 |
1 |
p. 13-22
10 p.
|
artikel
|
| 13 |
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non–Small-cell Lung Cancer: A Systematic Review and Meta-analysis
|
La Salvia, Anna
|
|
2017
|
18 |
1 |
p. 23-33.e1
308 p.
|
artikel
|
| 14 |
Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non–Small-Cell Lung Cancer
|
Zaki, Mark
|
|
2017
|
18 |
1 |
p. e21-e26
nvt p.
|
artikel
|
| 15 |
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe
|
Salahudeen, Ameen Abdulla
|
|
2017
|
18 |
1 |
p. 5-12
8 p.
|
artikel
|
| 16 |
Patterns of Distant Metastases After Surgical Management of Non–Small-cell Lung Cancer
|
Torok, Jordan A.
|
|
2017
|
18 |
1 |
p. e57-e70
nvt p.
|
artikel
|
| 17 |
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
|
Leighl, Natasha B.
|
|
2017
|
18 |
1 |
p. 34-42.e2
4167 p.
|
artikel
|
| 18 |
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease
|
Socinski, Mark A.
|
|
2017
|
18 |
1 |
p. 68-76.e2
7533 p.
|
artikel
|
| 19 |
Primary Tumor Location Is a Useful Predictor for Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
|
Sun, Wei
|
|
2017
|
18 |
1 |
p. e49-e55
nvt p.
|
artikel
|
| 20 |
Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer
|
Li, Tianhong
|
|
2017
|
18 |
1 |
p. 60-67
8 p.
|
artikel
|
| 21 |
Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non–Small-Cell Lung Cancer
|
Gao, Hong-Fei
|
|
2017
|
18 |
1 |
p. 85-91
7 p.
|
artikel
|
| 22 |
Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer
|
Jakubowski, Christopher D.
|
|
2017
|
18 |
1 |
p. e81-e83
nvt p.
|
artikel
|
| 23 |
Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy
|
Becker, Daniel J.
|
|
2017
|
18 |
1 |
p. e35-e40
nvt p.
|
artikel
|
| 24 |
Table of Contents
|
|
|
2017
|
18 |
1 |
p. A9-A13
nvt p.
|
artikel
|
| 25 |
Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non–Small-Cell Lung Cancer: Study Protocol
|
Ohashi, Kadoaki
|
|
2017
|
18 |
1 |
p. 92-95
4 p.
|
artikel
|
| 26 |
Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
|
Yoneshima, Yasuto
|
|
2017
|
18 |
1 |
p. 100-103
4 p.
|
artikel
|
| 27 |
Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer
|
Garon, Edward B.
|
|
2017
|
18 |
1 |
p. 96-99
4 p.
|
artikel
|
Tijdschrift beschrijving